Home

tung Utgående Att styra multiple sclerosis nature Andas in Okuvlig Prålig

The immunology of multiple sclerosis | Nature Reviews Immunology
The immunology of multiple sclerosis | Nature Reviews Immunology

Epstein–Barr virus sparks brain autoimmunity in multiple sclerosis
Epstein–Barr virus sparks brain autoimmunity in multiple sclerosis

Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a  complex concept | Nature Reviews Neurology
Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept | Nature Reviews Neurology

New concepts in the immunopathogenesis of multiple sclerosis | Nature  Reviews Neuroscience
New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience

Microglia clean up toxic lipids in multiple sclerosis | Nature Neuroscience
Microglia clean up toxic lipids in multiple sclerosis | Nature Neuroscience

Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the  Tail Been Wagging the Mouse?
Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

New concepts in the immunopathogenesis of multiple sclerosis | Nature  Reviews Neuroscience
New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience

New concepts in the immunopathogenesis of multiple sclerosis | Nature  Reviews Neuroscience
New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience

Multiple sclerosis | Nature Reviews Disease Primers
Multiple sclerosis | Nature Reviews Disease Primers

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

The immunology of multiple sclerosis | Nature Reviews Immunology
The immunology of multiple sclerosis | Nature Reviews Immunology

Multiple sclerosis - The Lancet
Multiple sclerosis - The Lancet

Multiple sclerosis | Nature Reviews Disease Primers
Multiple sclerosis | Nature Reviews Disease Primers

A molecular trio in relapse and remission in multiple sclerosis | Nature  Reviews Immunology
A molecular trio in relapse and remission in multiple sclerosis | Nature Reviews Immunology

Multiple sclerosis | Nature Reviews Disease Primers
Multiple sclerosis | Nature Reviews Disease Primers

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple  sclerosis | Nature
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis | Nature

Twin study reveals non-heritable immune perturbations in multiple sclerosis  | Nature
Twin study reveals non-heritable immune perturbations in multiple sclerosis | Nature

Positron emission tomography in multiple sclerosis — straight to the target  | Nature Reviews Neurology
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology

Immune-cell crosstalk in multiple sclerosis
Immune-cell crosstalk in multiple sclerosis

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

When encephalitogenic T cells collaborate with microglia in multiple  sclerosis | Nature Reviews Neurology
When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Mechanism-based criteria to improve therapeutic outcomes in progressive multiple  sclerosis | Nature Reviews Neurology
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Neuronal vulnerability and multilineage diversity in multiple sclerosis |  Nature
Neuronal vulnerability and multilineage diversity in multiple sclerosis | Nature

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple  sclerosis | Nature Reviews Drug Discovery
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery

Multiple sclerosis: a two-stage disease | Nature Immunology
Multiple sclerosis: a two-stage disease | Nature Immunology